Hyeon-Su Lee
Fortune : 7 384 $ au 31/05/2026
Fortune : 7 384 $ au 31/05/2026
Hyeon-Su Lee currently works at Pharosvaccine, as Director, Aprogen, Inc., as Independent Director from 2022, Seoul National University, as Professor, The National Academy of Engineering of Korea, as Member from 2012, and Korea Association of Procurement & Supply Management, as President from 2011.
Dr. Lee also formerly worked at Aprogen, Inc., as Independent Director, Samsung C&T Corp., as Independent Director, Samyang Genex Corp., as Chief Operating Officer & Executive Vice President, Celltrion, Inc., as President-New Business Development from 2002 to 2008, Architectural Institute of Korea, as President from 2018 to 2020, Korea Facility Management Association, as President from 2009 to 2010, and Korea Institute of Construction Engineering & Management, as President from 2007 to 2009.
Dr. Lee received his doctorate degree from the University of Michigan and undergraduate degree and graduate degree from Seoul National University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KUMHO Engineering & Construction Co., Ltd.
KUMHO Engineering & Construction Co., Ltd. Automotive AftermarketConsumer Durables Engages in the construction business 0,01% | 13/04/2026 | 2 734 ( 0,01% ) | 7 384 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| APROGEN MEDICINES INC. | Directeur/Membre du Conseil | 18/07/2022 |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The National Academy of Engineering of Korea | Corporate Officer/Principal | 01/01/2012 |
Korea Association of Procurement & Supply Management | President | 01/01/2011 |
Pharosvaccine | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Architectural Institute of Korea | President | 01/01/2020 |
Korea Facility Management Association | President | 01/01/2010 |
Korea Institute of Construction Engineering & Management | President | 01/01/2009 |
Celltrion, Inc. /Old/
Celltrion, Inc. /Old/ BiotechnologyHealth Technology Manufactures biomedical and pharmaceutical products | Corporate Officer/Principal | 02/09/2008 |
| ░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
Samyang Genex Corp.
Samyang Genex Corp. Agricultural Commodities/MillingProcess Industries Manufactures starches and glucose or maltose | Process Industries |
Aprogen, Inc.
Aprogen, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines development and carbon steel distribution services | Health Technology |
Celltrion, Inc. /Old/
Celltrion, Inc. /Old/ BiotechnologyHealth Technology Manufactures biomedical and pharmaceutical products | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
The National Academy of Engineering of Korea | |
Architectural Institute of Korea | |
Samsung C&T Corp.
Samsung C&T Corp. Engineering & ConstructionIndustrial Services Provides construction, engineering, trading, fashion and resort services | Industrial Services |
Korea Association of Procurement & Supply Management | |
Korea Facility Management Association | |
Korea Institute of Construction Engineering & Management | |
Pharosvaccine |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national